Shukra Pharmaceuticals Board Approves Name Change and Expansion into Medical Technology Sector
The Board of Directors of Shukra Pharmaceuticals Limited has approved a significant proposal aimed at evolving the company's structure and business focus, including changing its corporate name and expanding its scope of operations to embrace the medical technology industry.During a meeting held on August 14, 2026, the Board considered and sanctioned two major proposals. The first involves changing the company’s current name from "Shukra Pharmaceuticals Limited" to "Shukra Medtech Limited," or any other name that may be approved by relevant competent authorities.
The second proposal focuses on altering and expanding the existing Main Objects Clause of the Memorandum of Association. This expansion is intended to allow the company to actively engage in medical technology (MedTech) activities. These comprehensive activities include the development, manufacturing, designing, research and development, distribution, marketing, trading, and related pursuits concerning medical technology products, devices, equipment, systems, and solutions.
The planned transformation represents a strategic move for Shukra Pharmaceuticals Limited. The changes are intended to provide the company with a broader corporate identity, enabling it to pursue business opportunities within the booming medical technology sector, complementing its established activities in pharmaceuticals and healthcare. This initiative is part of the company's strategy to expand its presence across the healthcare and medical technology ecosystem, aiming to create opportunities for sustainable long-term growth.
The proposed name change and alteration of the Memorandum of Association are subject to the requisite approval by the shareholders and various other approvals, permissions, sanctions, and filings as required under applicable laws and regulations. The company will make further disclosures regarding the implementation process and the obtaining of necessary approvals when applicable.
SHUKRAPHAR Stock Price Movement
Today, shares of Shukra Pharmaceuticals Limited edged higher to close at ₹41.49 after gaining 0.61% in post-market trading. The stock recorded a total traded volume of 995,399 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.